acyclovir

(redirected from Sitavig)
Also found in: Thesaurus, Medical.
Related to Sitavig: acyclovir, Zovirax

a·cy·clo·vir

 (ā-sī′klō-vîr, -klə-)
n.
A synthetic purine nucleoside analog, C8H10N5O3, derived from guanine and used in the treatment of herpes simplex, herpes zoster, and varicella-zoster virus infections.

[acyclo(guanosine) (a- + cyclo- + guanosine) + (anti)vir(al).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

acyclovir

(eɪˈsaɪkləʊˌvɪə)
n
an antiviral drug used to treat herpes. Formula: C8H11N5O3
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

a•cy•clo•vir

(eɪˈsaɪ kloʊˌvɪər, -klə-)

n.
a synthetic crystalline compound, C18H11N5O3, used as an antiviral drug in the treatment of herpes infections.
[1980–85]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.acyclovir - an oral antiviral drug (trade name Zovirax) used to treat genital herpesacyclovir - an oral antiviral drug (trade name Zovirax) used to treat genital herpes; does not cure the disease but relieves the symptoms
medicament, medication, medicinal drug, medicine - (medicine) something that treats or prevents or alleviates the symptoms of disease
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

acyclovir

n aciclovir m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
M2 EQUITYBITES-August 1, 2017-Onxeo announces divestment of products Sitavig and Loramyc to Vectans Pharma for EUR4.0m upfront payment
* In April 2014, BioAlliance Pharma entered an exclusive supply and licence agreement for Sitavig (acyclovir Lauriad) with Daewoong Pharmaceutical for commercialisation rights in South Korea.
M2 PHARMA-March 19, 2014-BioAlliance Pharma signs licensing agreement for Sitavig in North America
M2 EQUITYBITES-March 19, 2014-BioAlliance Pharma signs licensing agreement for Sitavig in North America
BioAlliance Pharma SA (Paris:BIO.PA), a company dedicated to the development of orphan oncology and to supportive care products, announced today the issuance of two new patents for Sitavig (acyclovir mucoadhesive tablet) by the US and South Korean patent offices.
M2 EQUITYBITES-June 14, 2012-BioAlliance Pharma SA partners with Teva for licensing Sitavig in Israel(C)2012 M2 COMMUNICATIONS http://www.m2.com